Browsing Category
Pharma Industry News
4753 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Ichnos Glenmark presents data from Phase 1 study of ISB 2001 in multiple myeloma
In a presentation at the 66th American Society of Hematology Annual Meeting, Ichnos Glenmark Innovation (IGI) unveiled promising…
Cumberland Pharmaceuticals announces FDA approval for Acetadote’s simplified dosing regimen
Shares of Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) surged in after-hours trading following the announcement that the U.S. Food…
Paradigm Biopharmaceuticals scores A$16m investment—Here’s what it means for osteoarthritis treatment
Paradigm Biopharmaceuticals Ltd. (ASX: PAR) has secured a significant A$16 million in funding, positioning the company to launch…
Actinogen Medical progresses in XanaMIA Phase 2b/3 trial for Alzheimer’s disease
Actinogen Medical Limited (ASX: ACW) has announced a major milestone in its ongoing XanaMIA Phase 2b/3 clinical trial,…
Recce Pharmaceuticals secures approval for Phase 3 trial of R327G in Indonesia
Recce Pharmaceuticals Limited (ASX: RCE) has achieved a significant milestone in its quest to tackle diabetic foot infections…
Novartis company profile: A global leader redefining healthcare innovation
What is the history of Novartis and its establishment? Novartis emerged in 1996 following the merger of Ciba-Geigy…
Genmab’s epcoritamab therapy delivers promising results for relapsed follicular lymphoma
Relapsed or refractory follicular lymphoma (FL) remains a persistent challenge for patients, particularly those with high-risk features. Genmab…
Why BioAge Labs’ promising obesity drug trial of azelaprag came to an abrupt halt
BioAge Labs, a clinical-stage biopharmaceutical company focused on metabolic disease research, has announced the discontinuation of its STRIDES…
Suven Pharmaceuticals acquires majority stake in NJ Bio, strengthens US presence
Suven Pharmaceuticals Limited, a technology-focused contract development and manufacturing organisation (CDMO), has announced the acquisition of a controlling…
Cynata Therapeutics secures $8.1m funding after promising results from diabetic foot ulcers trial
Cynata Therapeutics Limited, a clinical-stage biotechnology company listed on the Australian Securities Exchange (ASX: CYP), has raised A$8.1…